Dr. Simsek began by emphasizing that their group had previously shown that CD8+ T cells expressing PD-1 but lacking TIM-3 or LAG-3 are associated with improved clinical outcomes to anti–PD-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback